Skip to primary content
Skip to secondary content

Biotech 365

Main menu

  • Biotech 365
  • Companies
  • Healthcare Investors
    • Healthcare LPs
  • Healthcare Investors Matchmaking
  • Free DEMO
  • Services
    • Preclinical Studies Database
    • Scientific Due Diligence
    • CRO & CDMO Database
  • Contact

Tag Archives: Rabbe Klemets

Mobidiag – molecular diagnostics

Posted on by

Mobidiag is a biotech company specialized in rapid diagnostics of infectious diseases. Mobidiag aims to improve healthcare quality and fight antimicrobial resistance by offering the cutting-edge molecular diagnostic methods.

Mobidiag – molecular diagnostics

mobidiag Continue reading →

Posted in Biotech Companies, Biotech Companies Finland | Tagged 027 ribotype, Albert Hsia, Amplidiag, Amplidiag Bacterial GE, Amplidiag C. difficile, Amplidiag C. difficile+027, antibiotic resistance, antibiotic resistance marker, antibiotic resistance markers, antimicrobial resistance, biobank, C. difficile, Göran Pettersson, Jean de Gunzburg, Juha Kirveskari, Kingella kingae, methicillin, methicillin resistance, microarray, Mobidiag, Mobidiag - molecular diagnostics, Mobidiag Ltd, molecular diagnostic, molecular diagnostics, PCR amplification, Prove-it, Prove-it Advisor, Prove-it Biobank, Prove-it Bone&Joint, Prove-it Herpes, Prove-it Sepsis, Prove-it StripArray, Prove-it TubeArray, QMS, quality management system, Rabbe Klemets, ribotype, Robert Harju-Jeanty, Tuomas Tenkanen, vancomycin, vancomycin resistance

        Services              Healthcare Investors Database              FAQs               CGU               Biotech & Pharma News             Contact
Proudly powered by WordPress